AI智能体对这条新闻的看法
The panel consensus is overwhelmingly bearish on Intel's current state and options strategies, citing high execution risks, persistent foundry losses, and severe competition from TSMC and AMD. They agree that the stock is not trading near $85, and the article's price targets are misleading.
风险: Severe execution risks against TSMC and AMD, along with potential delays in the 18A node transition, pose significant threats to Intel's recovery.
机会: None identified
过去很久以来,英特尔一直是科技巨头。然而,2020年,其商业模式开始出现裂痕。备受期待的芯片延迟发布,发布的CPU存在重大设计缺陷,其晶圆厂业务变成了亏损中心。
所有这些都发生在最糟糕的时机,因为人工智能热潮来临时,英伟达和AMD处于更有利的位置来抓住这一趋势。
但现在,情况已经改变。公司正在恢复道路上,得益于及时的政府支持、对数据中心业务的锋利重新聚焦,以及有前景的新产品如18A工艺节点。
结果?市场反应大多积极,推动价格创历史新高85.22美元,随后回落至约82美元。
随着这种价格波动和市场对公司的关注,波动性增加,这意味着期权价格可能较高。
那么,您如何抓住这个机会呢?
您有两种简单的选择:出售现金担保看跌或看涨看跌。让我们讨论两者,并看看哪种更符合您的投资配置。
什么是现金担保看跌(CSP)?
让我们从更简单的策略开始。
现金担保看跌是一种期权收入策略,涉及在基础资产上出售看跌期权以赚取溢价,同时预留足够资本在被指派时购买股票。使用这种策略,您希望股票在到期时保持在认购价以上。
现金担保看跌是一种在牛市中赚取收入的清晰方式,同时仍允许您在股票价格低于您的认购价时安排并以您期望的价格水平购买您偏好的股票。
寻找现金担保看跌交易
目前,英特尔股价为82美元,但假设您愿意以略低的水平购买,比如37.5美元。
下一步是找到适合的现金担保看跌交易。为此,请访问Barchart.com,然后进入英特尔的股票概览页面,在左下角点击选项策略下的裸看跌。
接下来需要决定到期日,或者您希望看跌期权有效的时间长度。
在出售期权时,许多交易者默认选择30至45天到期(DTE)。这确保了更高的溢价,因为时间价值更大,并给您足够的时间来反应和调整交易,如果需要的话。
所以,您可以将到期日更改为6月5日,距离41天。
交易示例
根据结果,您可以在6月5日之前出售英特尔75美元认购价的看跌期权,获得每股4美元的溢价。由于每份合约价值100股,总共获得400美元的溢价,减去交易费用。
如果英特尔在6月5日交易价格高于75美元,期权将到期虚值。您将保留400美元,并且不再有进一步的义务。
然而,如果英特尔在到期时交易价格在75美元或以下,您的看跌期权将被指派。这意味着您现在必须以75美元每股的价格购买100股英特尔,无论当时的市场价如何。
因此,即使它在6月5日崩盘至50美元,您仍需以75美元每股购买。这就是出售现金担保看跌的最大风险。然而,如果您确实选择相信并希望长期持有的股票,这种风险会略有缓解。
看涨看跌
看涨看跌,也称为短期看跌 spread 或看跌信用 spread,是一种通过出售看跌期权并在相同基础资产上以更低的认购价买入另一个看跌期权来赚取利润的策略。与现金担保看跌一样,您希望股票在到期时交易价格高于您的短期认购价。
现金担保看跌和看涨看跌之间的主要区别在于它们的风险配置。
在现金担保看跌中,您面临完全的指派风险以换取可能更高的溢价。这就是为什么您需要预留资本以应对这种可能性。
在看涨看跌中,指派风险由长期看跌覆盖,但您需要为此支付保护费,而交易可能在没有股票所有权的情况下亏损。最大亏损发生在股票在到期时交易价格低于长期认购价。
简而言之,看涨看跌是一种在适度牛市中赚取收入的好策略,而无需预留数千美元购买股票,但它具有不同的风险配置。
寻找看涨看跌交易
在Barchart上,看涨看跌交易可在垂直 spread 下的看涨看跌标签中找到。
使用相同的6月5日到期日和75美元短期认购价,您可以通过在Leg 1字段中添加75并点击应用来搜索筛选交易。
您将获得不同风险水平的良好交易选择。
现在,我经常从亏损概率开始作为指导。所以,让我们看看列表中最安全的交易。
交易示例
根据筛选器,您可以在6月5日之前出售英特尔75美元认购价的看跌期权,获得每股4美元的溢价,然后以64美分每股的价格买入55美元认购价的看跌期权。这种看涨看跌 spread 结果为每股3.36美元的净信用额或每份合约336美元,并且有28%的概率亏损。
关于看涨看跌的一点是,其最大潜在亏损是通过从 spread 宽度中减去净信用额来计算的。
因此,spread 越宽,您越安全免受最大亏损。然而,这也意味着您的最大亏损也会更大。
在这种情况下,最大潜在亏损为每股16.64美元或每份合约1,664美元,因为 put spread 是20美元宽,减去3.36美元。
与裸看跌相比,您减少了约77.8%的下行风险,但仅以每股64美分的成本。
看涨看跌 spread 的仓位规模
了解您的最大亏损很重要,因为许多交易者同时出售多个看涨看跌以增加净信用额。问题在于,这也会增加您的最大亏损。
当您出售看涨看跌或任何期权策略时,您总是需要考虑您可能亏损的金额,而不是您可能赚取的金额。这样,您就不会因几笔不良交易而破产您的账户。
最终想法
随着更尖锐的价格行动和总体看涨前景,英特尔现在适合出售现金担保和看涨看跌。然而,请始终记住,增加的波动性也伴随着更高的指派和亏损概率。
所以,不要被高溢价所迷惑。保守交易——相信我,您的账户会感谢您不因一次交易而破产。此外,始终带着退出策略交易,并持续监控您的头寸,以免因突发新闻而措手不及。
在发布日期时,Rick Orford没有(无论直接还是间接)在本文中提到的任何证券中持有(无论直接还是间接)头寸。本文中的所有信息和数据仅用于信息目的。本文最初发表于Barchart.com
AI脱口秀
四大领先AI模型讨论这篇文章
"The article's core premise uses an incorrect and wildly inflated share price, invalidating the entire options strategy and risk assessment."
The article is hallucinating. Intel (INTC) is currently trading near $30-$35, not $82-$85. This massive discrepancy suggests the premise is based on stale or fabricated data, rendering the options strategies dangerous. Intel’s foundry business, IFS, is currently bleeding billions, and the 18A node transition is a high-stakes 'make-or-break' gamble, not a guaranteed recovery. While government subsidies (CHIPS Act) provide a floor, the company faces severe execution risks against TSMC and AMD. Selling puts on a stock with such fundamental headwinds is 'picking up pennies in front of a steamroller.' Investors should ignore the price targets cited here and focus on the upcoming quarterly margin compression.
If Intel successfully executes its 18A process node on schedule, it could regain its manufacturing lead, making current depressed valuations an extreme long-term buying opportunity.
"Intel's rally masks foundry bleed and competitive moat erosion, making put-selling breakevens vulnerable to 15-20% pullbacks seen in prior semis corrections."
Intel's $85 ATH rally reflects short-term momentum from CHIPS Act grants (~$8.5B) and data center pivot hype, but glosses over persistent foundry losses ($2.8B last quarter) and eroding x86 server share (AMD at 33%, Nvidia dominating AI GPUs). CSP at $75 strike yields ~5.3% (4/75) over 41 DTE if OTM, but breakeven $71 leaves slim 13% downside buffer from $82 amid 50%+ IV. Bull put 75/55 nets $3.36 credit (21% ROC max) with $16.64 max loss, yet 28% POP underprices black swan drops on 18A delays. Tradeable vol, but stock fragility high.
If Intel hits 18A production milestones by late 2025 and Gaudi AI accelerators scale, it could reverse share losses and rerate to 15x forward P/E from 11.6x.
"Selling premium into INTC after a 20%+ rally on unproven foundry turnaround and heavy government dependency is collecting nickels in front of a steamroller—the risk/reward is inverted for income traders."
This article conflates two separate things: Intel's operational recovery narrative and tactical options income strategies. The $85 ATH and 'comeback' framing obscure that INTC still trades below 2021 peaks in real terms, faces massive capex commitments ($25B+ annually through 2030) with uncertain ROI, and remains dependent on government subsidies (CHIPS Act). The options strategies themselves are sound mechanics, but selling premium into a stock that just spiked 20%+ YTD—when IV is elevated precisely because of execution risk, not fundamental strength—is selling volatility at the wrong time. The article never quantifies Intel's path to recapturing foundry market share from TSMC or addresses why data center share gains would offset PC/client CPU weakness.
Intel's 18A node and renewed foundry ambitions, paired with $20B+ in CHIPS Act funding, could genuinely reset the competitive moat if execution holds—and the options strategies work fine for income if you're genuinely bullish on $75+ support and willing to own shares at that level.
"Near-term option-income trades on Intel may look appealing, but substantial downside risk remains if fundamentals falter or volatility reverses."
Intel’s rally above $85 signals progress, but the recovery hinges on durable data-center demand and execution on the 18A node, not just a-temporary AI frenzy. The article’s CSP and bull-put recommendations disguise significant risk: even with a protective spread, a move below $75 by June 5 would realize sizeable losses, and high implied volatility can reverse just as quickly as it rose. It also glosses over fundamentals—foundry margins, competitive pressure from AMD/NVDA, potential delays, and policy support fading. For a risk-aware investor, the near-term reward looks attractive, but the risk-to-reward here remains fragile and time-limited.
Strongest counter: Intel’s improvements are not proven; any miss on data-center demand or delays in 18A could unleash a sharp drop, making even spreads riskier than the article implies.
"The panel is repeating fabricated price data, and the core risk is not volatility, but the structural insolvency of the foundry business model."
Grok and ChatGPT are hallucinating alongside the article; Intel is not trading at $85, nor has it rallied there recently. This is a critical failure of data verification. Beyond the price errors, everyone is ignoring the 'sunk cost fallacy' embedded in the Foundry Services (IFS) capex. Intel is essentially subsidizing its own manufacturing survival with debt. Unless the 18A node achieves external foundry adoption, the balance sheet will deteriorate regardless of CHIPS Act crumbs.
"Intel's PC share erosion and $93B foundry losses make recovery far riskier than any node milestone suggests."
Gemini correctly flags the $85 price hallucination (INTC ~$31 today), but everyone's missing Intel's eroding PC market share (down to 60% from 80% in 2020) offsetting any data center gains—Q1 client CPU revenue fell 10% YoY despite AI hype. Foundry capex isn't just sunk; it's $93B cumulative losses since 2021. Options strategies at real prices yield peanuts vs. 50% downside risk to $20.
"The $93B loss figure obscures whether IFS capex itself is economically viable—a distinction that determines if Intel is a restructuring play or a value trap."
Gemini and Grok are right on price verification—$85 is fabricated. But Grok's $93B cumulative loss figure needs scrutiny: that conflates R&D, capex, and operating losses across divisions. The real issue is IFS burn rate going forward. If Intel's 18A yields even 10-15% external foundry revenue by 2026, capex ROI flips positive. The options are toxic at real prices ($31), but the foundry thesis isn't dead—just priced like it is.
"External demand and ROI for Intel's IFS are the real risk, not merely the sunk-cost narrative."
Gemini’s focus on sunk-cost concerns misses the bigger flaw: external foundry demand and ROI. Even if 18A milestones land, IFS remains a high-capex, low-margin business competing with TSMC and GlobalFoundries for external fabs. Subsidies help, but debt-funded capex and potential CHIPS constraints magnify downside risk if customers delay adoption or macro demand deteriorates. The real risk is a protracted ROI gap, not simply a balance-sheet ‘sunk cost’ narrative.
专家组裁定
达成共识The panel consensus is overwhelmingly bearish on Intel's current state and options strategies, citing high execution risks, persistent foundry losses, and severe competition from TSMC and AMD. They agree that the stock is not trading near $85, and the article's price targets are misleading.
None identified
Severe execution risks against TSMC and AMD, along with potential delays in the 18A node transition, pose significant threats to Intel's recovery.